APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pneumonia Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pneumonia Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025187 pages

Choose your research edition.

Industry ResearchPneumonia Therapeutics Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Pneumonia Therapeutics Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Pneumonia Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pneumonia Therapeutics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pneumonia Therapeutics Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Pneumonia Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pneumonia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pneumonia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pneumonia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pneumonia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pneumonia Therapeutics include Novartis, Pfizer, GlaxoSmithKline, Bayer, AstraZeneca, Tetraphase Pharmaceuticals, Merck Sharp & Dohme and Biotest, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pneumonia Therapeutics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pneumonia Therapeutics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pneumonia Therapeutics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pneumonia Therapeutics market size, projected growth trends, production technologies, key applications, and end-use industries.

Pneumonia Therapeutics Segment by Company

Novartis

Pfizer

GlaxoSmithKline

Bayer

AstraZeneca

Tetraphase Pharmaceuticals

Merck Sharp & Dohme

Biotest

Pneumonia Therapeutics Segment by Type

Vaccines

Anti-Infectives

Oxygen Therapy

Pneumonia Therapeutics Segment by Application

Clinic

Hospital

Medical Center

Other

Pneumonia Therapeutics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumonia Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pneumonia Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumonia Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pneumonia Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pneumonia Therapeutics industry.

Chapter 3: Detailed analysis of Pneumonia Therapeutics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pneumonia Therapeuticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pneumonia Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Vaccines Table 3. Key Players of Anti-Infectives Table 4. Key Players of Oxygen Therapy Table 4. Global Pneumonia Therapeutics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Clinic Table 6. Key Players of Hospital Table 7. Key Players of Medical Center Table 8. Key Players of Other Table 9. Global Pneumonia Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Pneumonia Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Pneumonia Therapeutics Market Share by Region (2021-2026) Table 12. Global Pneumonia Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Pneumonia Therapeutics Market Share by Region (2027-2032) Table 14. Pneumonia Therapeutics Industry Trends Table 15. Pneumonia Therapeutics Industry Drivers Table 16. Pneumonia Therapeutics Industry Opportunities and Challenges Table 17. Pneumonia Therapeutics Industry Restraints Table 18. Global Pneumonia Therapeutics Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Pneumonia Therapeutics Revenue Market Share by Company (2021-2026) Table 20. Global Pneumonia Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pneumonia Therapeutics Key Company Head Office and Area Served Table 22. Global Pneumonia Therapeutics Company, Product Type & Application Table 23. Global Pneumonia Therapeutics Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Pneumonia Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Pneumonia Therapeutics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pneumonia Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Pneumonia Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Pneumonia Therapeutics Revenue Market Share by Type (2021-2026) Table 30. Global Pneumonia Therapeutics Revenue Market Share by Type (2027-2032) Table 31. Global Pneumonia Therapeutics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pneumonia Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Pneumonia Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Pneumonia Therapeutics Revenue Market Share by Application (2021-2026) Table 35. Global Pneumonia Therapeutics Revenue Market Share by Application (2027-2032) Table 36. Novartis Company Information Table 37. Novartis Business Overview Table 38. Novartis Pneumonia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Novartis Pneumonia Therapeutics Product Portfolio Table 40. Novartis Recent Development Table 41. Pfizer Company Information Table 42. Pfizer Business Overview Table 43. Pfizer Pneumonia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Pfizer Pneumonia Therapeutics Product Portfolio Table 45. Pfizer Recent Development Table 46. GlaxoSmithKline Company Information Table 47. GlaxoSmithKline Business Overview Table 48. GlaxoSmithKline Pneumonia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. GlaxoSmithKline Pneumonia Therapeutics Product Portfolio Table 50. GlaxoSmithKline Recent Development Table 51. Bayer Company Information Table 52. Bayer Business Overview Table 53. Bayer Pneumonia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Bayer Pneumonia Therapeutics Product Portfolio Table 55. Bayer Recent Development Table 56. AstraZeneca Company Information Table 57. AstraZeneca Business Overview Table 58. AstraZeneca Pneumonia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. AstraZeneca Pneumonia Therapeutics Product Portfolio Table 60. AstraZeneca Recent Development Table 61. Tetraphase Pharmaceuticals Company Information Table 62. Tetraphase Pharmaceuticals Business Overview Table 63. Tetraphase Pharmaceuticals Pneumonia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Tetraphase Pharmaceuticals Pneumonia Therapeutics Product Portfolio Table 65. Tetraphase Pharmaceuticals Recent Development Table 66. Merck Sharp & Dohme Company Information Table 67. Merck Sharp & Dohme Business Overview Table 68. Merck Sharp & Dohme Pneumonia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Merck Sharp & Dohme Pneumonia Therapeutics Product Portfolio Table 70. Merck Sharp & Dohme Recent Development Table 71. Biotest Company Information Table 72. Biotest Business Overview Table 73. Biotest Pneumonia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Biotest Pneumonia Therapeutics Product Portfolio Table 75. Biotest Recent Development Table 76. North America Pneumonia Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 77. North America Pneumonia Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 78. North America Pneumonia Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 79. North America Pneumonia Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 80. North America Pneumonia Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Pneumonia Therapeutics Market Size by Country (2021-2026) Table 82. North America Pneumonia Therapeutics Market Size by Country (2027-2032) Table 83. Europe Pneumonia Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 84. Europe Pneumonia Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 85. Europe Pneumonia Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 86. Europe Pneumonia Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 87. Europe Pneumonia Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Europe Pneumonia Therapeutics Market Size by Country (2021-2026) Table 89. Europe Pneumonia Therapeutics Market Size by Country (2027-2032) Table 90. China Pneumonia Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 91. China Pneumonia Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 92. China Pneumonia Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 93. China Pneumonia Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 94. Asia Pneumonia Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 95. Asia Pneumonia Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 96. Asia Pneumonia Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 97. Asia Pneumonia Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 98. Asia Pneumonia Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Asia Pneumonia Therapeutics Market Size by Country (2021-2026) Table 100. Asia Pneumonia Therapeutics Market Size by Country (2027-2032) Table 101. South America, Middle East & Africa Pneumonia Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 102. South America, Middle East & Africa Pneumonia Therapeutics Market Size by Type (2027-2032) & (US$ Million) Table 103. South America, Middle East & Africa Pneumonia Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 104. South America, Middle East & Africa Pneumonia Therapeutics Market Size by Application (2027-2032) & (US$ Million) Table 105. South America, Middle East & Africa Pneumonia Therapeutics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. South America, Middle East & Africa Pneumonia Therapeutics Market Size by Country (2021-2026) Table 107. South America, Middle East & Africa Pneumonia Therapeutics Market Size by Country (2027-2032) Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Pneumonia Therapeutics Product Image Figure 2. Global Pneumonia Therapeutics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pneumonia Therapeutics Market Share by Type: 2025 VS 2032 Figure 4. Vaccines Image Figure 5. Anti-Infectives Image Figure 6. Oxygen Therapy Image Figure 7. Global Pneumonia Therapeutics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Pneumonia Therapeutics Market Share by Application: 2025 VS 2032 Figure 9. Clinic Image Figure 10. Hospital Image Figure 11. Medical Center Image Figure 12. Other Image Figure 13. Global Pneumonia Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 15. Global Pneumonia Therapeutics Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Pneumonia Therapeutics Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Pneumonia Therapeutics Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Pneumonia Therapeutics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pneumonia Therapeutics Revenue Market Share by Type (2021-2032) Figure 22. Global Pneumonia Therapeutics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Pneumonia Therapeutics Revenue Market Share by Application (2021-2032) Figure 24. North America Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 25. North America Pneumonia Therapeutics Market Share by Type (2021-2032) Figure 26. North America Pneumonia Therapeutics Market Share by Application (2021-2032) Figure 27. North America Pneumonia Therapeutics Market Share by Country (2021-2032) Figure 28. United States Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 29. Canada Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 31. Europe Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 32. Europe Pneumonia Therapeutics Market Share by Type (2021-2032) Figure 33. Europe Pneumonia Therapeutics Market Share by Application (2021-2032) Figure 34. Europe Pneumonia Therapeutics Market Share by Country (2021-2032) Figure 35. Germany Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 36. France Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 38. Italy Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 39. Russia Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 41. China Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 42. China Pneumonia Therapeutics Market Share by Type (2021-2032) Figure 43. China Pneumonia Therapeutics Market Share by Application (2021-2032) Figure 44. Asia Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 45. Asia Pneumonia Therapeutics Market Share by Type (2021-2032) Figure 46. Asia Pneumonia Therapeutics Market Share by Application (2021-2032) Figure 47. Asia Pneumonia Therapeutics Market Share by Country (2021-2032) Figure 48. Japan Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 52. India Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 53. Australia Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Pneumonia Therapeutics Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Pneumonia Therapeutics Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Pneumonia Therapeutics Market Share by Country (2021-2032) Figure 58. Brazil Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 63. UAE Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 65. Chile Pneumonia Therapeutics Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Vaccines
  • Anti-Infectives
  • Oxygen Therapy
Applications
  • Clinic
  • Hospital
  • Medical Center
  • Other
Companies covered
  • Novartis
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • Tetraphase Pharmaceuticals
  • Merck Sharp & Dohme
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pneumonia Therapeutics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Vaccines
  5. 1.2.3 Anti-Infectives
  6. 1.2.4 Oxygen Therapy
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Pneumonia Therapeutics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Clinic
  10. 1.3.3 Hospital
  11. 1.3.4 Medical Center
  12. 1.3.5 Other
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Pneumonia Therapeutics Growth Trends by Region
  15. 1.5.1 Global Pneumonia Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Pneumonia Therapeutics Market Size by Region (2021-2026)
  17. 1.5.3 Pneumonia Therapeutics Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Pneumonia Therapeutics Market Dynamics
  1. 2.1 Pneumonia Therapeutics Industry Trends
  2. 2.2 Pneumonia Therapeutics Industry Drivers
  3. 2.3 Pneumonia Therapeutics Industry Opportunities and Challenges
  4. 2.4 Pneumonia Therapeutics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pneumonia Therapeutics Revenue by Company (2021-2026)
  2. 3.2 Global Pneumonia Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pneumonia Therapeutics Key Company Head office and Area Served
  4. 3.4 Global Pneumonia Therapeutics Company, Product Type & Application
  5. 3.5 Global Pneumonia Therapeutics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pneumonia Therapeutics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pneumonia Therapeutics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pneumonia Therapeutics Tier 1, Tier 2, and Tier 3
4 Pneumonia Therapeutics Market by Type
  1. 4.1 Global Pneumonia Therapeutics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pneumonia Therapeutics Market Size by Type (2021-2032)
  3. 4.3 Global Pneumonia Therapeutics Market Size Share by Type (2021-2032)
5 Pneumonia Therapeutics Market by Application
  1. 5.1 Global Pneumonia Therapeutics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pneumonia Therapeutics Market Size by Application (2021-2032)
  3. 5.3 Global Pneumonia Therapeutics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Pneumonia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novartis Pneumonia Therapeutics Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Pneumonia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Pfizer Pneumonia Therapeutics Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline Pneumonia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 GlaxoSmithKline Pneumonia Therapeutics Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 Bayer
  20. 6.4.1 Bayer Company Information
  21. 6.4.2 Bayer Business Overview
  22. 6.4.3 Bayer Pneumonia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Bayer Pneumonia Therapeutics Product Portfolio
  24. 6.4.5 Bayer Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Pneumonia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 AstraZeneca Pneumonia Therapeutics Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Tetraphase Pharmaceuticals
  32. 6.6.1 Tetraphase Pharmaceuticals Company Information
  33. 6.6.2 Tetraphase Pharmaceuticals Business Overview
  34. 6.6.3 Tetraphase Pharmaceuticals Pneumonia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Tetraphase Pharmaceuticals Pneumonia Therapeutics Product Portfolio
  36. 6.6.5 Tetraphase Pharmaceuticals Recent Developments
  37. 6.7 Merck Sharp & Dohme
  38. 6.7.1 Merck Sharp & Dohme Company Information
  39. 6.7.2 Merck Sharp & Dohme Business Overview
  40. 6.7.3 Merck Sharp & Dohme Pneumonia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Merck Sharp & Dohme Pneumonia Therapeutics Product Portfolio
  42. 6.7.5 Merck Sharp & Dohme Recent Developments
  43. 6.8 Biotest
  44. 6.8.1 Biotest Company Information
  45. 6.8.2 Biotest Business Overview
  46. 6.8.3 Biotest Pneumonia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Biotest Pneumonia Therapeutics Product Portfolio
  48. 6.8.5 Biotest Recent Developments
7 North America
  1. 7.1 North America Pneumonia Therapeutics Market Size (2021-2032)
  2. 7.2 North America Pneumonia Therapeutics Market Size by Type
  3. 7.2.1 North America Pneumonia Therapeutics Market Size by Type (2021-2026)
  4. 7.2.2 North America Pneumonia Therapeutics Market Size by Type (2027-2032)
  5. 7.2.3 North America Pneumonia Therapeutics Market Share by Type (2021-2032)
  6. 7.3 North America Pneumonia Therapeutics Market Size by Application
  7. 7.3.1 North America Pneumonia Therapeutics Market Size by Application (2021-2026)
  8. 7.3.2 North America Pneumonia Therapeutics Market Size by Application (2027-2032)
  9. 7.3.3 North America Pneumonia Therapeutics Market Share by Application (2021-2032)
  10. 7.4 North America Pneumonia Therapeutics Market Size by Country
  11. 7.4.1 North America Pneumonia Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pneumonia Therapeutics Market Size by Country (2021-2026)
  13. 7.4.3 North America Pneumonia Therapeutics Market Size by Country (2027-2032)
  14. 7.4.4 North America Pneumonia Therapeutics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pneumonia Therapeutics Market Size (2021-2032)
  2. 8.2 Europe Pneumonia Therapeutics Market Size by Type
  3. 8.2.1 Europe Pneumonia Therapeutics Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pneumonia Therapeutics Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pneumonia Therapeutics Market Share by Type (2021-2032)
  6. 8.3 Europe Pneumonia Therapeutics Market Size by Application
  7. 8.3.1 Europe Pneumonia Therapeutics Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pneumonia Therapeutics Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pneumonia Therapeutics Market Share by Application (2021-2032)
  10. 8.4 Europe Pneumonia Therapeutics Market Size by Country
  11. 8.4.1 Europe Pneumonia Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pneumonia Therapeutics Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pneumonia Therapeutics Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pneumonia Therapeutics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pneumonia Therapeutics Market Size (2021-2032)
  2. 9.2 China Pneumonia Therapeutics Market Size by Type
  3. 9.2.1 China Pneumonia Therapeutics Market Size by Type (2021-2026)
  4. 9.2.2 China Pneumonia Therapeutics Market Size by Type (2027-2032)
  5. 9.2.3 China Pneumonia Therapeutics Market Share by Type (2021-2032)
  6. 9.3 China Pneumonia Therapeutics Market Size by Application
  7. 9.3.1 China Pneumonia Therapeutics Market Size by Application (2021-2026)
  8. 9.3.2 China Pneumonia Therapeutics Market Size by Application (2027-2032)
  9. 9.3.3 China Pneumonia Therapeutics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pneumonia Therapeutics Market Size (2021-2032)
  2. 10.2 Asia Pneumonia Therapeutics Market Size by Type
  3. 10.2.1 Asia Pneumonia Therapeutics Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pneumonia Therapeutics Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pneumonia Therapeutics Market Share by Type (2021-2032)
  6. 10.3 Asia Pneumonia Therapeutics Market Size by Application
  7. 10.3.1 Asia Pneumonia Therapeutics Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pneumonia Therapeutics Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pneumonia Therapeutics Market Share by Application (2021-2032)
  10. 10.4 Asia Pneumonia Therapeutics Market Size by Country
  11. 10.4.1 Asia Pneumonia Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pneumonia Therapeutics Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pneumonia Therapeutics Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pneumonia Therapeutics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pneumonia Therapeutics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pneumonia Therapeutics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pneumonia Therapeutics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pneumonia Therapeutics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pneumonia Therapeutics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pneumonia Therapeutics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pneumonia Therapeutics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pneumonia Therapeutics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pneumonia Therapeutics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pneumonia Therapeutics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pneumonia Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pneumonia Therapeutics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pneumonia Therapeutics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pneumonia Therapeutics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst